tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Fatty Liver D005234 48 associated lipids
Precancerous Conditions D011230 48 associated lipids
Psoriasis D011565 47 associated lipids
Leukemia P388 D007941 43 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Hypotension D007022 41 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Shirakata Y et al. Inhibitory effect of plasma FKBP12 on immunosuppressive activity of FK506. 1995 Transplantation pmid:8545894
Aoyama H et al. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment. 1995 Br. J. Dermatol. pmid:8547017
Gharpure VS et al. Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation. 1995 Bone Marrow Transplant. pmid:8547871
Koch K et al. CP-123,369: a potent, orally active immunosuppressive agent. 1995 Inflamm. Res. pmid:8548388
Hamasaki Y et al. Inhibition of leukotriene production by FK506 in rat basophilic leukemia-1 cells. 1995 Pharmacology pmid:7538218
Clardy J The chemistry of signal transduction. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7529414
Braun W et al. Three-dimensional structure and actions of immunosuppressants and their immunophilins. 1995 FASEB J. pmid:7529736
Kawai M et al. Pyrrolidine dithiocarbamate inhibits intercellular adhesion molecule-1 biosynthesis induced by cytokines in human fibroblasts. 1995 J. Immunol. pmid:7532665
Venkataraman L et al. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. 1995 J. Exp. Med. pmid:7532676
Wang CR et al. T cell receptor-mediated signaling events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection. 1995 J. Exp. Med. pmid:7532685
Martinez OM et al. Molecular markers of Epstein-Barr virus infection in the circulation of transplant recipients. 1995 Transplant. Proc. pmid:7533372
Fung JJ and Starzl TE FK506 in solid organ transplantation. 1995 Ther Drug Monit pmid:8588226
Langrehr JM et al. Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis. 1995 Transplant. Proc. pmid:7533373
Jusko WJ Analysis of tacrolimus (FK 506) in relation to therapeutic drug monitoring. 1995 Ther Drug Monit pmid:8588227
Vargas V et al. Alpha-interferon for acute hepatitis C in liver transplant patients. 1995 Transplant. Proc. pmid:7533374
McMaster P et al. Therapeutic drug monitoring of tacrolimus in clinical transplantation. 1995 Ther Drug Monit pmid:8588228
Barkholt LM et al. New criteria for diagnosing cytomegalovirus hepatitis in liver transplant patients. 1995 Transplant. Proc. pmid:7533375
Jusko WJ et al. Consensus document: therapeutic monitoring of tacrolimus (FK-506). 1995 Ther Drug Monit pmid:8588229
Teraoka S et al. Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantation. 1995 Transplant. Proc. pmid:7533381
Lohse DL et al. Insights derived from the structures of the Ser/Thr phosphatases calcineurin and protein phosphatase 1. 1995 Structure pmid:8590008
Fay JW et al. FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation. 1995 Transplant. Proc. pmid:7533383
Shapiro R et al. A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. 1995 Transplant. Proc. pmid:7533432
Winkler M et al. Comparison of plasma vs whole blood as matrix for FK 506 drug level monitoring. 1995 Transplant. Proc. pmid:7533433
Sakamoto K et al. Sodium-losing nephropathy and distal tubular damage of transplant kidneys with FK506 administration. 1995 Transplant. Proc. pmid:7533434
Ochiai T et al. Phase III study of FK 506 in kidney transplantation. Japanese FK 506 Study Group. 1995 Transplant. Proc. pmid:7533435
Scantlebury VP et al. Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome. 1995 Transplant. Proc. pmid:7533436
Hanafusa T et al. Long-term impact of hepatitis virus infection on kidney transplant recipients and a pilot study of the effects of interferon alpha on chronic hepatitis C. 1995 Transplant. Proc. pmid:7533440
Iwasaki K et al. Further metabolism of FK506 (tacrolimus). Identification and biological activities of the metabolites oxidized at multiple sites of FK506. 1995 Drug Metab. Dispos. pmid:7536652
Tumlin JA et al. Expression of calcineurin activity and alpha-subunit isoforms in specific segments of the rat nephron. 1995 Am. J. Physiol. pmid:7485542
Furukawa F et al. FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice. 1995 Arch. Dermatol. Res. pmid:7487142
Miranker A and Karplus M An automated method for dynamic ligand design. 1995 Proteins pmid:8749844
Marumo T et al. Cyclosporin A inhibits nitric oxide synthase induction in vascular smooth muscle cells. 1995 Hypertension pmid:7536714
Nowaczyk M et al. 2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506). 1995 Arch. Immunol. Ther. Exp. (Warsz.) pmid:8744655
Schwaninger M et al. Involvement of the Ca(2+)-dependent phosphatase calcineurin in gene transcription that is stimulated by cAMP through cAMP response elements. 1995 J. Biol. Chem. pmid:7536740
Min Z and Jones NF Limb transplantation in rats: immunosuppression with FK-506. 1995 J Hand Surg Am pmid:7536766
Lyons WE et al. Neuronal regeneration enhances the expression of the immunophilin FKBP-12. 1995 J. Neurosci. pmid:7536825
Yamamoto S et al. Cross-species transplantation of photoreceptors with tacrolimus hydrate (FK506) treatment. 1995 Jpn. J. Ophthalmol. pmid:8926639
Lam E et al. A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor. 1995 J. Biol. Chem. pmid:7592869
Kanda T et al. Synergistic effects of tacrolimus and human interferon-alpha A/D in murine viral myocarditis. 1995 J. Pharmacol. Exp. Ther. pmid:7542339
Canzanello VJ et al. Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation. 1995 J. Am. Soc. Nephrol. pmid:7542491
Conde M et al. Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity. 1995 Immunology pmid:7538492
Garrett-Engele P et al. Calcineurin, the Ca2+/calmodulin-dependent protein phosphatase, is essential in yeast mutants with cell integrity defects and in mutants that lack a functional vacuolar H(+)-ATPase. 1995 Mol. Cell. Biol. pmid:7542741
Skeen MJ and Ziegler HK Activation of gamma delta T cells for production of IFN-gamma is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12. 1995 J. Immunol. pmid:7538532
Baughman G et al. FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. 1995 Mol. Cell. Biol. pmid:7542743
Columbo M et al. Human skin mast cells express functional beta 1 integrins that mediate adhesion to extracellular matrix proteins. 1995 J. Immunol. pmid:7538541
Pearlman DA and Connelly PR Determination of the differential effects of hydrogen bonding and water release on the binding of FK506 to native and Tyr82-->Phe82 FKBP-12 proteins using free energy simulations. 1995 J. Mol. Biol. pmid:7538591
Sauer P et al. In patients with orthotopic liver transplantation, serum markers of cholestasis are unreliable indicators of biliary secretion. 1995 J. Hepatol. pmid:7544368
Chang HY et al. Asymmetric retraction of growth cone filopodia following focal inactivation of calcineurin. 1995 Nature pmid:7544441
Murio JE et al. Compassionate use of FK 506 in liver transplantation. 1995 Transplant. Proc. pmid:7544501
Llull R et al. Multilineage amplification of graft-vs-host disease-resistant chimerism following rat vascularized bone marrow allotransplantation. 1995 Transplant. Proc. pmid:7544504
Horne SM and Young KD Escherichia coli and other species of the Enterobacteriaceae encode a protein similar to the family of Mip-like FK506-binding proteins. 1995 Arch. Microbiol. pmid:7540828
Teutsch M et al. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin. 1995 Int. Immunol. pmid:7540861
Hoshino H et al. Effects of FK506 on an experimental model of colitis in rats. 1995 Aliment. Pharmacol. Ther. pmid:7544633
Mori A et al. IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. 1995 Int. Immunol. pmid:7540862
Tashiro H et al. Monitoring for engraftment following rat orthotopic liver transplantation by in vitro amplification of Y-chromosome gene using polymerase chain reaction. 1995 Cell Transplant pmid:7540919
Hikita N et al. Effects of topical FK506 on endotoxin-induced uveitis (EIU) in the Lewis rat. 1995 Curr. Eye Res. pmid:7540967
Cardenas ME et al. Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A. 1995 EMBO J. pmid:7540976
Mueller AR et al. The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506? 1995 Clin Transplant pmid:7549057
Nagai H et al. Effect of some immunosuppressors on allergic bronchial inflammation and airway hyperresponsiveness in mice. 1995 Int. Arch. Allergy Immunol. pmid:7549508
Jung-Testas I et al. Cyclosporin A promotes nuclear transfer of a cytoplasmic progesterone receptor mutant. 1995 C. R. Acad. Sci. III, Sci. Vie pmid:7583777
Kissinger CR et al. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. 1995 Nature pmid:8524402
Lauerma AI Immunomodulation of contact dermatitis. 1995 Curr. Probl. Dermatol. pmid:7587333
Cardenas ME et al. Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin. 1995 Curr. Opin. Nephrol. Hypertens. pmid:8591053
Cameron AM et al. Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux. 1995 Cell pmid:8521476
Tamura K FK506: mechanism of immunosuppression and adverse-effects. 1995 J Toxicol Sci pmid:8531246
Díaz M et al. [Tacrolimus (FK 506): an immunosuppression alternative in solid organ transplantation. (Part 2)]. 1995 Apr-Jun Rev Med Univ Navarra pmid:7569553
Hisatomi K et al. Effect of dose of cyclosporine or FK506 and antithrombotic agents on cardiac allograft vascular disease in heterotopically transplanted hearts in rats. 1995 Jan-Feb J. Heart Lung Transplant. pmid:7537098
Díaz M et al. [Tacrolimus (FK 506): immunosuppressive alternative to solid organ transplant (Part 1)]. 1995 Jan-Mar Rev Med Univ Navarra pmid:14735715
Kawahara K et al. Effects of deoxyspergualin on bronchial anastomosis healing in canine pulmonary allografts. 1995 Jul-Aug J. Heart Lung Transplant. pmid:7578196
Motoyama K et al. Pretransplant intrathymic inoculation of donor antigen combined with FK506 treatment: prolongation of survival of cardiac, but not renal, allografts in rats. 1995 Mar-Apr World J Surg pmid:7538717
Okudaira H et al. Enhanced production and gene expression of interleukin-5 in patients with bronchial asthma: possible management of atopic diseases by down-regulation of interleukin-5 gene transcription. 1995 May-Jun Int. Arch. Allergy Immunol. pmid:7542077
Su Q et al. Nephrotoxicity of cyclosporin A and FK506: inhibition of calcineurin phosphatase. 1995 May-Jun Ren. Physiol. Biochem. pmid:7542793
Hayashi S et al. Evidence that donor pretreatment with FK506 has a synergistic effect on graft prolongation in hamster-to-rat heart xenotransplantation. 1995 May-Jun J. Heart Lung Transplant. pmid:7544621
Castillo Lugo JA Clinical and experimental immunosuppression. 1995 May-Jun Bol Asoc Med P R pmid:8573248
Seifeldin R Drug interactions in transplantation. 1995 Nov-Dec Clin Ther pmid:8750397
Schreiber SL and Crabtree GR Immunophilins, ligands, and the control of signal transduction. 1995-1996 Harvey Lect. pmid:9127988
Panyi G et al. Immunosuppressors inhibit voltage-gated potassium channels in human peripheral blood lymphocytes. 1996 Biochem. Biophys. Res. Commun. pmid:8619842
Kiang D et al. Cloning the gene encoding Schistosoma mansoni p50, an immunophilin. 1996 Gene pmid:8621074
Sung RS et al. Survival of human islet xenografts irradiated with ultraviolet B in diabetic rats. 1996 Transplant. Proc. pmid:8623427
Stratta RJ et al. FK 506 induction and rescue therapy in pancreas transplant recipients. 1996 Transplant. Proc. pmid:8623492
Fay JW et al. FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation. 1996 Blood pmid:8605372
Greeno EW et al. Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor ABO incompatibility. 1996 Transfusion pmid:8607158
Weinzweig N et al. Peripheral-nerve allotransplantation in rats immunosuppressed with transient or long-term FK-506. 1996 J Reconstr Microsurg pmid:8905545
Nagai H et al. The role of interleukin-5 (IL-5) in allergic airway hyperresponsiveness in mice. 1996 Ann. N. Y. Acad. Sci. pmid:8906215
Brunner T et al. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506. 1996 Int. Immunol. pmid:8757947
Gusev AI et al. A quantitative study of in vitro hepatic metabolism of tacrolimus (FK506) using secondary ion and matrix-assisted laser desorption/ionization mass spectrometry. 1996 Rapid Commun. Mass Spectrom. pmid:8759330
Corey HE et al. Improved renal allograft survival in children treated with FK 506 (tacrolimus) rescue therapy. 1996 Pediatr. Nephrol. pmid:8971888
Fändrich F et al. Circumvention of natural killer cell and T-cell mediated allogeneic target killing with tacrolimus (FK506) in small bowel transplantation related graft-vs-host disease. 1996 Transpl. Int. pmid:8959843
Antoniou E et al. Effect of RS61443 in combination with leflunomide or FK506 on rat heart allograft survival. 1996 Transpl. Int. pmid:8959858
Licitra EJ and Liu JO A three-hybrid system for detecting small ligand-protein receptor interactions. 1996 Proc. Natl. Acad. Sci. U.S.A. pmid:8917502
Woodle ES et al. Treatment of acute glomerular rejection with FK 506. 1996 Clin Transplant pmid:8826664
Yamashita M et al. Non-T cell-derived IL-4 plays an important role in IgE production induced by antigen resensitization and is resistant to FK506. 1996 J. Immunol. pmid:8752921
Silva ND and Prendergast FG Tryptophan dynamics of the FK506 binding protein: time-resolved fluorescence and simulations. 1996 Biophys. J. pmid:8785272
Devine SM et al. Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation. 1996 Bone Marrow Transplant. pmid:8879619
Ikegami S et al. A facilitatory effect on the induction of long-term potentiation in vivo by chronic administration of antisense oligodeoxynucleotides against catalytic subunits of calcineurin. 1996 Brain Res. Mol. Brain Res. pmid:8883951
Zou XM et al. Immunosuppressive effect of FK506 on orthotopic liver and small bowel xenotransplantation (xenoOLTx and SBTx). 1996 Transplant. Proc. pmid:8658729
Kokado Y et al. Hypertension in renal transplant recipients and its effect on long-term renal allograft survival. 1996 Transplant. Proc. pmid:8658802
Takuma T et al. Dephosphorylation of cofilin in parotid acinar cells. 1996 J. Biochem. pmid:8864841
Shaw LM et al. Toxic effects of immunosuppressive drugs: mechanisms and strategies for controlling them. 1996 Clin. Chem. pmid:8697605
Dhar DK et al. FK506 maintains cellular calcium homeostasis in ischemia-reperfusion injury of the canine liver. 1996 J. Surg. Res. pmid:8592405